Hypophosphataemia: treatments, associated drugs and conditions

Summary:

Hypophosphataemia: electrolyte disturbance in which there is an abnormally low level of phosphate in the blood.

We study 10,530 people who have Hypophosphataemia. The information that eHealthMe analyzes includes:

- Medications that treat Hypophosphataemia and their effectiveness
- 869 drugs that are associated with Hypophosphataemia


eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


Number of reports submitted per year:

Hypophosphataemia: 10,530 reports.

All the drugs that are associated with Hypophosphataemia:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.



Recent studies on eHealthMe: